Looking to buy BPC-157 or TB-500 in the UK? Nova Biolabs stocks a pre-blended BPC-157 / TB-500 10mg vial from UK domestic stock, HPLC-verified at >98% purity, with same or next-day discreet dispatch.
BPC-157 (Body Protective Compound 157) is a synthetic pentadecapeptide comprising 15 amino acids. The sequence is derived from a protein found in human gastric juice. It has been the subject of extensive in vitro and animal model research studying tissue repair signalling, mucosal protection pathways, and connective tissue biology.
BPC-157 does not have an approved clinical application. All research involves in vitro or animal model work, and the compound is supplied strictly for laboratory research purposes.
TB-500 refers to the active fragment of Thymosin Beta-4, a naturally occurring actin-sequestering protein. The specific fragment studied — sometimes called the Ac-SDKP tetrapeptide — has been investigated extensively in cell and tissue models for its roles in cell migration, angiogenesis, and anti-inflammatory signalling.
Thymosin Beta-4 and its fragments are subjects of ongoing research interest in wound healing biology, angiogenesis pathway research, and connective tissue cell models.
The two peptides are frequently studied together because they target complementary aspects of tissue repair biology. BPC-157 has been primarily studied in gastrointestinal mucosal and connective tissue models, while TB-500 research focuses more on angiogenesis, cell migration, and systemic anti-inflammatory pathways.
Research examining whether the two compounds produce additive or synergistic effects in tissue repair models has generated significant interest, making the blend a practical and popular research combination.
Both compounds have been studied in various in vitro models examining aspects of tissue healing, including fibroblast migration, collagen synthesis, and extracellular matrix remodelling.
TB-500 has been studied for its interaction with VEGF signalling pathways and effects on endothelial cell migration — key processes in angiogenesis research models.
BPC-157's gastric origin has made it a focus of research in gastrointestinal mucosal cell models, studying mucosal protection and repair signalling pathways.
Both peptides have been studied in tendon, muscle, and connective tissue cell lines for their effects on repair-associated signalling.
The BPC-157 / TB-500 blend is available from Nova Biolabs as a pre-blended 10mg lyophilised vial at £60, from UK domestic stock with same/next day dispatch.
All Nova Biolabs peptides are research grade, HPLC-verified and held in UK stock for same or next-day dispatch.
Browse All Products →